SCHEMBL7184673

SCHEMBL7184673

CCCc1ccc(OCC)c(/C=C/C(=O)c2ccc(C(=O)N(C)C)cc2)c1OCC

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
LMNA P02545 5/20 0.44
ALDH1A1 P00352 3/20 0.44
POLB P06746 1/20 0.44
CYP1A1 P04798 5/20 0.42
CYP1B1 Q16678 5/20 0.42
CYP1A2 P05177 4/20 0.42
CYP2D6 P10635 4/20 0.42
MAOB P27338 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAOA P21397 1/20 0.39
KMT2A Q03164 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184677 1.00 MAPT (0.44) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7183714 0.90 ABCG2 (0.41) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7185393 0.89 ABCG2 (0.42) MAOBABCG2
SCHEMBL7187702 0.88 ABCG2 (0.51) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7187705 0.88 ABCG2 (0.51) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7177462 0.87 PTPN1 (0.46) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7177465 0.87 PTPN1 (0.46) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7183451 0.87 CYP1B1 (0.44) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7183455 0.87 CYP1B1 (0.44) MAPTLMNAALDH1A1POLBCYP1A1
SCHEMBL7184722 0.86 LMNA (0.50) MAPTLMNAALDH1A1POLBCYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed